by James Ross Kelly

FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression | Live Science


The FDA is helping to speed up the process of developing and approving a drug based on psilocybin, a hallucinogenic substance in magic mushrooms, to treat depression.

Source: FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression | Live Science

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.